Traverso I, Soncini D, Giorgetti G, Ravera S, Ivanisevic J, Garibotto M, Gallo M, Guolo F, Cagnetta A, Lemoli R, Cea M. P100 | Enhanced NAD⁺ biosynthesis and PPP activation drive venetoclax resistance in multiple myeloma: therapeutic reversal by NAMPT inhibition: I. Traverso1, D. Soncini1|2, G. Giorgetti2, S. Ravera3, J. Ivanisevic4, M. Garibotto2, M. Gallo1, F. Guolo1|2, A. Cagnetta2, R.M. Lemoli1|2, M. Cea1|2 | 1Clinic of Hematology, Department of Internal Medicine and Medical Specialties DiMI, University of Genoa; 2IRCCS Ospedale Policlinico San Martino; 3Department of Experimental Medicine DIMES, University of Genoa, Italy 4Metabolomics Unit, Faculty of Biology and Medicine, University of Lausanne, Switzerland. haematol [Internet]. 2026Mar.3 [cited 2026Oct.2];111(s1). Available from: https://haematologica.org/article/view/haematol.2026.s1.157